SCHEMBL3370418

SCHEMBL3370418

CC1CC1NC(=O)c1cccc(-c2ccc(C(=O)NN)cc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.48
TRPM8 Q7Z2W7 1/20 0.47
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
HDAC8 Q9BY41 1/20 0.42
TRPV1 Q8NER1 1/20 0.42
SMYD3 Q9H7B4 2/20 0.42
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
TAS1R2 Q8TE23 1/20 0.42
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3793085 0.83 ALDH1A1 (0.59) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL25700071 0.77 ALDH1A1 (0.68) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL28254875 0.77 ALDH1A1 (0.68) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL15978923 0.75 TDP1 (0.59) TRPM8MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL315040 0.75 HDAC8 (0.70) KDM4EALDH1A1HDAC8
SCHEMBL29781370 0.75 TDP1 (0.59) TRPM8MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL29781372 0.75 TDP1 (0.59) TRPM8MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL18231413 0.75 TDP1 (0.59) TRPM8MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL1904111 0.72 ALDH1A1 (0.70) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL9056834 0.71 CRBN (0.61) NPC1RAB9APOLBMAPTCTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1990338-B1 Biphenylcyclopropylamides as p-38 Kinase inhibitors NOVARTIS AG (CH) 2010-09-22 EP disclosed
EP-1990338-A2 Biphenylcyclopropylamides as p-38 Kinase inhibitors Novartis AG (CH) 2008-11-12 EP disclosed